Investor Relations

Latest Annual Filing

Fiscal Year Ended Mar 31, 2018

View Filing

Stock Information

Company Overview

Bionik Laboratories (OTCQB: BNKL) is a global, pioneering robotics company focused on providing rehabilitation solutions to individuals with neurological disorders. Through the acquisition of Interactive Motion Technologies, Bionik has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients. The Company now has three products available on the market and three products in varying stages of development.

The InMotion Systems - the InMotion ARM™, InMotion WRIST™, InMotion HAND™ and InMotion ANKLE™, are designed to provide intelligent, patient-adaptive therapy in a manner that has been clinically verified to maximize neuro-recovery. The Company is also developing a lower-body exoskeleton, ARKE™, designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking.

Each of Bionik’s products are or are expected to be designed to continually adapt to a patient’s ability and provide real time feedback to the physiotherapist through the use of Bionik’s proprietary data collection and analytics cloud network through its partnership with IBM.

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Bionik Laboratories Corp.
483 Bay Street
Office N105
Toronto, ON M5G 2C9
Canada
T: 416-640-7887
info@bioniklabs.com

Investor Relations

Leslie Markow CPA CA CPA (Illinois) C. Dir.
Chief Financial Officer
T: 416 402-3694
lm@bioniklabs.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
www.vstocktransfer.com